These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38549086)

  • 1. External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a retrospective single-center cohort study in Japan.
    Arakaki D; Iwata M; Terasawa T
    Thromb J; 2024 Mar; 22(1):31. PubMed ID: 38549086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Padua and IMPROVE-VTE Risk Assessment Models for Predicting Venous Thromboembolism in Hospitalized Adult Medical Patients: A Retrospective Single-Center Study in Japan.
    Arakaki D; Iwata M; Terasawa T
    Ann Vasc Dis; 2023 Mar; 16(1):60-68. PubMed ID: 37006863
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score.
    Villiger R; Julliard P; Darbellay Farhoumand P; Choffat D; Tritschler T; Stalder O; Rossel JB; Aujesky D; Méan M; Baumgartner C
    Thromb Res; 2023 Oct; 230():37-44. PubMed ID: 37634309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Internal Validation of the Cleveland Clinic Bleeding Model to Predict Major Bleeding Risk at Admission in Medical Inpatients.
    Mittman BG; Sheehan M; Kojima L; Casacchia NJ; Lisheba O; Hu B; Pappas MA; Rothberg MB
    J Thromb Haemost; 2024 Jul; ():. PubMed ID: 39002732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
    Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
    Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
    Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
    Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
    Chi G; Violi F; Pignatelli P; Vestri A; Spagnoli A; Loffredo L; Hernandez AF; Hull RD; Cohen AT; Harrington RA; Goldhaber SZ; Gibson CM
    J Thromb Thrombolysis; 2023 Feb; 55(2):211-221. PubMed ID: 36566304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Risk Assessment Model Predicts Major Bleeding Risk at Admission in Medical Inpatients.
    Mittman BG; Sheehan M; Kojima L; Cassachia N; Lisheba O; Hu B; Pappas M; Rothberg MB
    medRxiv; 2023 May; ():. PubMed ID: 37205327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population.
    Wilkinson KS; Sparks AD; Gergi M; Repp AB; Al-Samkari H; Thomas R; Roetker NS; Zakai NA
    Res Pract Thromb Haemost; 2024 May; 8(4):102441. PubMed ID: 38953050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
    Stuck AK; Spirk D; Schaudt J; Kucher N
    Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
    Goldin M; Lin SK; Kohn N; Qiu M; Cohen SL; Barish MA; Gianos E; Diaz A; Richardson S; Giannis D; Chatterjee S; Coppa K; Hirsch JS; Ngu S; Firoozan S; McGinn T; Spyropoulos AC
    J Thromb Thrombolysis; 2021 Nov; 52(4):1032-1035. PubMed ID: 34146235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.